Based on these theories, we investigated the changes in cancer stem cell population expressed CD133 and CD44, which are well known colorectal cancer stem cell surface markers caused by 5-Fu, metformin, and combination treatments. This evidence concerns the gene PROM1 and colorectal cancer.